Cargando…

Trojan triplets: RNA-based pathomechanisms for muscle dysfunction in Huntington’s disease

Detalles Bibliográficos
Autores principales:	Skov, Martin, Dirksen, Robert T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2017
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217092/ https://www.ncbi.nlm.nih.gov/pubmed/27940949 http://dx.doi.org/10.1085/jgp.201611728

Ejemplares similares

Prairie Dog: Cuddly Pet or Trojan Horse?
por: Azad, Abdu F.
Publicado: (2004)

miR-34a-5p as molecular hub of pathomechanisms in Huntington’s disease
por: Hart, Martin, et al.
Publicado: (2023)

Huntington’s disease skeletal muscle has altered T-tubules
por: Khan, Muhammad S., et al.
Publicado: (2021)

Tyrosine-Phosphorylated Bacterial Proteins: Trojan Horses for the Host Cell
por: Covacci, Antonello, et al.
Publicado: (2000)

A shared mechanism of muscle wasting in cancer and Huntington’s disease
por: Mielcarek, Michal, et al.
Publicado: (2015)

Skeletal Muscle Modulates Huntington’s Disease Pathogenesis in Mice: Role of Physical Exercise
por: Corrochano, Silvia, et al.
Publicado: (2018)

Circular RNAs as Trojan horses of leukaemia: A promising path to cancer precision medicine
por: Conn, Vanessa M., et al.
Publicado: (2023)

Cervicogenic visual dysfunction: an understanding of its pathomechanism
por: Leung, Kingsley King Yi, et al.
Publicado: (2023)

Rectifying rectifier channels in Huntington disease
por: Proft, Juliane, et al.
Publicado: (2014)

New developments in Huntington’s disease and other triplet repeat diseases: DNA repair turns to the dark side
por: Lahue, Robert S.
Publicado: (2020)

Wet-Spun Trojan Horse Cell Constructs for Engineering Muscle
por: Quigley, Anita F., et al.
Publicado: (2020)

Synaptopathy, circuitopathy and the computational biology of Huntington’s disease
por: Hannan, Anthony J.
Publicado: (2018)

Neural Compensation in Huntington's Disease: Teaching Mental Disorders New Tricks?
por: Wolf, Robert Christian, et al.
Publicado: (2015)

HIV and Mature Dendritic Cells: Trojan Exosomes Riding the Trojan Horse?
por: Izquierdo-Useros, Nuria, et al.
Publicado: (2010)

Phenotypic Variability in Huntington's Disease
por: Chouksey, Anjali, et al.
Publicado: (2020)

Implications of the Orb2 Amyloid Structure in Huntington’s Disease
por: Hervás, Rubén, et al.
Publicado: (2020)

Nucleolar and Ribosomal Dysfunction—A Common Pathomechanism in Childhood Progerias?
por: Phan, Tamara, et al.
Publicado: (2019)

Ribosomal Dysfunction Is a Common Pathomechanism in Different Forms of Trichothiodystrophy
por: Zhu, Gaojie, et al.
Publicado: (2023)

The Innovative Medicines Fund: a universal model for faster and fairer access to new promising medicines or a Trojan horse for low-value creep?
por: Angelis, Aris, et al.
Publicado: (2023)

Olfactory Dysfunction in Huntington’s Disease
por: Patino, Jorge, et al.
Publicado: (2021)

Pathomechanisms of Prenatally Programmed Adult Diseases
por: Sulyok, Endre, et al.
Publicado: (2023)

Pathomechanisms of Autoimmune Based Testicular Inflammation
por: Lustig, Livia, et al.
Publicado: (2020)

Compensation in the course of Huntington's disease — More than just a hypothesis?
por: Schiefer, Johannes
Publicado: (2015)

Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date
por: Squitieri, Ferdinando, et al.
Publicado: (2015)

Supporting Huntington’s Disease Families Through the Ups and Downs of Clinical Trials
por: Andrew, Kelly M., et al.
Publicado: (2023)

Invisible Trojan-horse attack
por: Sajeed, Shihan, et al.
Publicado: (2017)

The Trojan Chicken Study, Minnesota
por: Olson, Sandra R., et al.
Publicado: (2006)

Trojan Microparticles for Drug Delivery
por: Anton, Nicolas, et al.
Publicado: (2012)

Trojan mosquitoes control dengue
por: Cunha, Andreia
Publicado: (2021)

Resurrection of sildenafil: potential for Huntington’s Disease, too?
por: Achenbach, Jannis, et al.
Publicado: (2022)

Alternative RNA Splicing—The Trojan Horse of Cancer Cells in Chemotherapy
por: Mehterov, Nikolay, et al.
Publicado: (2021)

Natural Trojan horse inhibitors of aminoacyl-tRNA synthetases
por: Travin, Dmitrii Y., et al.
Publicado: (2021)

Raising Awareness of Therapeutic Misconception and Optimism Around Clinical Trials in Huntington’s Disease
por: de Bot, Susanne Tamara
Publicado: (2019)

Rosiglitazone Ameliorates Cardiac and Skeletal Muscle Dysfunction by Correction of Energetics in Huntington’s Disease
por: Tomczyk, Marta, et al.
Publicado: (2022)

An immunometabolic pathomechanism for chronic obstructive pulmonary disease
por: Bruzzaniti, Sara, et al.
Publicado: (2019)

Corticostriatal Dysfunction in Huntington’s Disease: The Basics
por: Bunner, Kendra D., et al.
Publicado: (2016)

Conclusions of the SIGNAL study in Huntington and implications for treatment of other slowly progressive neurodegenerative diseases
por: Zauderer, Maurice, et al.
Publicado: (2023)

The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases
por: Sommer, Annika, et al.
Publicado: (2017)

Pathomechanisms of Immunological Disturbances in β-Thalassemia
por: Gluba-Brzózka, Anna, et al.
Publicado: (2021)

Novel pathomechanisms in inflammatory neuropathies
por: Schafflick, David, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bjgjv6q3jsq44c0shpntrrsvj2